Pharmaceutical Commerce - January/February 2010

March 24, 2010

Growing digitization of patient data could break the threshold to better adherence to medication therapies

March 24, 2010

The Medical Affairs function can play a vital role in today’s product launch process

March 24, 2010

Over half of all physicians are participating in social-media sites or online professional networks

March 12, 2010

March 03, 2010

How the many anticounterfeiting measures on the market today could turn into a means of connecting with patients

March 03, 2010

Class-wide opioid REMS will affect four million patients and require cooperation of more than 25 drug manufacturers

March 03, 2010

March 03, 2010

More and more parts of the healthcare industry are connecting

March 03, 2010

Preparing for the effects of economic recovery on a changed logistics landscape is the theme

February 26, 2010

IT developer promotes concept of 'revenue management life cycle'

February 25, 2010

Old software and poor data quality cause both revenue losses and extra expense to reconcile claims. Will serialized packages provide an eventual cure?

February 25, 2010

While researchers study new pain-killing pathways, the pharma industry tries drug combinations and alternative-delivery mechanisms By Angelo DePalma, PhD

February 25, 2010

Shared-risk or ‘pay for performance’ agreements between drugmakers and payers can represent uncertain rewards for both parties. Use strategic planning before entering into them

February 25, 2010

Kaiser Permanente files a citizen’s petition to revise FDA’s process of imposing REMS programs, also objects to restrictions on wholesale-distribution

February 25, 2010

In competing for pharmacy business, AmerisourceBergen, Cardinal Health and McKesson offer improved access to branded and generic products

February 25, 2010

Long in the making, could become finalized before the end of the year

February 23, 2010

Sharps Compliance Corp. lauds California law to raise the profile of proper consumer disposal of used sharps. Next up: unused pharmaceutical returns

February 22, 2010

February 22, 2010

Capsugel will provide nano-encryption for capsules through technology license

February 22, 2010

Forbes magazine survey finds top nine drugs, all costing >$200,000 annually

February 18, 2010

Only sites certified by NABP (in the US) and CIPA (Canada) will be allowed to purchase AdWords

February 18, 2010

The growth of healthcare business is attracting many new players to the pharmaceutical arena, challenging pharma’s relationships with patients

February 18, 2010

Drugmaker will collaborate with Web startup to develop personalized healthcare plans

February 18, 2010

USDA program started around when the FDA program did, and encountered similar problems

February 18, 2010

Patient Outcomes Research Moves Drug Development Beyond Clinical Results

February 18, 2010

Latest 10-year BLS projection sees moderate growth in US employment—except for ‘top executives’

February 18, 2010

While time- and temperature-sensitive biopharma shipping will grow dramatically in coming years, the capacity of air freight carriers is becoming constrained

February 03, 2010

Two industry communications agencies hope an online collaboration will lead to joint service offerings

January 26, 2010

Long in the making, could become finalized before the end of the year

January 22, 2010

European anticounterfeiting project tests end-to-end authentication

January 22, 2010

Launch includes a delayed-release formulation, in-house and contract sales force, a REMS program and a patient-adherence program

January 22, 2010

Kaiser Permanente files a citizen’s petition to revise FDA’s process of imposing REMS programs; also objects to restrictions on wholesale-distribution

January 22, 2010

CRM vendor invests in data sources to upgrade its offerings for life sciences regulatory and marketing operations

January 08, 2010

Sharps Compliance Corp. lauds California law to raise the profile of proper consumer disposal of used sharps

January 08, 2010

Participants will meet quarterly throughout the year to create supply chain use-scenarios with GS1 standards

January 08, 2010

Updated survey finds some improvements, but little overall progress since a 2006 survey

January 08, 2010

In the past year, FDA has imposed REMS programs for one out of four new drug approvals